The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development

Richard Grose1, Vera Fantl, Sabine Werner

  • 1Centre for Tumour Biology, Institute of Cancer, Bart's & The London, Queen Mary's School of Medicine & Dentistry, London, UK. r.p.grose@qmul.ac.uk

The EMBO Journal
|February 17, 2007
PubMed

Insights

Fibroblast growth factor receptor 2b (Fgfr2b) deletion in skin cells causes hair and gland abnormalities. Loss of Fgfr2b also increases skin cancer susceptibility, revealing its tumor suppressive role.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Developmental Biology

Background:

  • The epithelial fibroblast growth factor receptor 2b (Fgfr2b) is critical for embryonic development, with null mutations causing embryonic lethality.
  • Its role in post-natal skin development and homeostasis remains largely unexplored.

Purpose of the Study:

  • To investigate the function of Fgfr2b in adult skin development and homeostasis.
  • To determine the role of Fgfr2b in skin carcinogenesis and inflammatory responses.

Main Methods:

  • Utilized Cre-Lox transgenic technology to specifically delete Fgfr2b in keratin 5-expressing epidermal cells.
  • Analyzed skin phenotype, tumor development after chemical carcinogen exposure, and gene expression profiles in mutant mice.

Main Results:

  • Mice lacking epidermal Fgfr2b survived to adulthood but exhibited hair and sebaceous gland abnormalities, epidermal hyperthickening, and spontaneous papilloma formation.
  • Mutant mice showed increased sensitivity to chemical carcinogens, developing papillomas and squamous cell carcinomas, alongside heightened skin inflammation with altered immune cell populations.
  • Gene expression analysis revealed increased interleukin 18 and decreased Serpin a3b in mutant skin.

Conclusions:

  • Fgfr2b plays a crucial role in post-natal skin development, homeostasis, and suppresses tumor formation in the epidermis.
  • This study provides the first evidence of a tyrosine kinase receptor functioning as a tumor suppressor in the skin.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.